ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,009.60
      0.00%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.175
      -0.13%
      Bitcoin
      67,314.80
      -1.24%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Acasti Pharma Inc (ACST)

      7. Acasti Pharma Inc (ACST) Financials

      Acasti Pharma Inc

      Acasti Pharma Inc (ACST)

      Acasti Pharma Inc
      2.84
      0.00
      (0.00%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Acasti Pharma Inc Financial Summary

      The current ACST market cap is 26.69M. The company's latest EPS is USD -1.3674 and P/E is -0.42.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -42.42M-3.51M-2.69M-2.28M-8.85M
      Net Income -29.09M-4.02M-3.27M-2.39M-3.17M
      Year End March 30 2024 20202021202220232024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0196k000
      Operating Income -24.44M-16.01M-15.34M-52.16M-12.85M
      Net Income -25.51M-19.68M-9.82M-42.43M-12.85M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 79.12M73.03M78.21M76.19M73.3M
      Total Liabilities 11.17M9.02M11.47M11.51M11.56M
      Total Equity 67.96M64.01M66.75M64.68M61.74M
      Year End March 30 2024 20202021202220232024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 22.85M62.46M128.62M79.12M73.3M
      Total Liabilities 9.86M6.8M20.35M11.17M11.56M
      Total Equity 12.99M55.66M108.27M67.96M61.74M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -15.91M-6.24M-8.35M-10.25M-12.33M
      Investing 13.15M N/A 110k-6.44M104k
      Financing 304k N/A 7.36M7.36M7.36M
      Year End March 30 2024 20202021202220232024
      CAD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -22.94M-14.32M-17.23M-15.91M-12.33M
      Investing 8.14M-9.86M-3.52M13.15M104k
      Financing 13.18M59.49M N/A 304k7.36M

      Stats and Ratios

      Market Cap 26.69M
      Price to Earnings Ratio -0.42
      Price to Sales Ratio 0
      Price to Cash Ratio 0.24
      Price to Book Ratio 0.09
      Dividend Yield -

      Share Statistics

      Shares Outstanding 9.4M
      Average Volume (1 week) 9.28k
      Average Volume (1 Month) 10.2k
      52 Week Change 9.65%
      52 Week High 3.59
      52 Week Low 1.72
      Spread (Intraday) 0.16 (5.44%)

      Company Info

      Company Name Acasti Pharma Inc
      Address 3009 boul. de la concorde east, suite 102
      quebec city, quebec H7E 2B5
      Website https://www.acastipharma.com
      Industry pharmaceutical preparations (2834)